1. Home
  2. POCI vs INTS Comparison

POCI vs INTS Comparison

Compare POCI & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POCI
  • INTS
  • Stock Information
  • Founded
  • POCI 1982
  • INTS 2012
  • Country
  • POCI United States
  • INTS United States
  • Employees
  • POCI N/A
  • INTS N/A
  • Industry
  • POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • POCI Health Care
  • INTS Health Care
  • Exchange
  • POCI Nasdaq
  • INTS Nasdaq
  • Market Cap
  • POCI 32.4M
  • INTS 33.4M
  • IPO Year
  • POCI N/A
  • INTS 2023
  • Fundamental
  • Price
  • POCI $4.21
  • INTS $2.23
  • Analyst Decision
  • POCI
  • INTS Strong Buy
  • Analyst Count
  • POCI 0
  • INTS 3
  • Target Price
  • POCI N/A
  • INTS $8.50
  • AVG Volume (30 Days)
  • POCI 7.6K
  • INTS 26.6K
  • Earning Date
  • POCI 02-13-2025
  • INTS 03-13-2025
  • Dividend Yield
  • POCI N/A
  • INTS N/A
  • EPS Growth
  • POCI N/A
  • INTS N/A
  • EPS
  • POCI N/A
  • INTS N/A
  • Revenue
  • POCI $18,682,766.00
  • INTS N/A
  • Revenue This Year
  • POCI N/A
  • INTS N/A
  • Revenue Next Year
  • POCI N/A
  • INTS N/A
  • P/E Ratio
  • POCI N/A
  • INTS N/A
  • Revenue Growth
  • POCI N/A
  • INTS N/A
  • 52 Week Low
  • POCI $3.47
  • INTS $1.50
  • 52 Week High
  • POCI $6.90
  • INTS $5.94
  • Technical
  • Relative Strength Index (RSI)
  • POCI 24.49
  • INTS 49.26
  • Support Level
  • POCI $4.75
  • INTS $1.84
  • Resistance Level
  • POCI $5.04
  • INTS $2.27
  • Average True Range (ATR)
  • POCI 0.25
  • INTS 0.28
  • MACD
  • POCI -0.08
  • INTS -0.01
  • Stochastic Oscillator
  • POCI 0.00
  • INTS 56.36

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

Share on Social Networks: